Insider Trading April 10, 2026 05:58 PM

NPK International CFO Disposes $225,675 in Stock via Pre-Arranged Plan

Sale executed under a Rule 10b5-1 plan after company reported stronger-than-expected Q4 2025 results; shares trade near 52-week high

By Avery Klein NPKI
NPK International CFO Disposes $225,675 in Stock via Pre-Arranged Plan
NPKI

Gregg Piontek, Senior Vice President and Chief Financial Officer of NPK International (NPKI), sold 15,000 shares on April 9, 2026 under a Rule 10b5-1 trading arrangement. The transaction, executed at a weighted average price of $15.045, totaled $225,675. The trade occurred as NPKI stock trades near its 52-week high following a quarter that beat earnings and revenue estimates, while an InvestingPro Fair Value assessment indicates the shares may be overvalued.

Key Points

  • NPK International CFO Gregg Piontek sold 15,000 shares on April 9, 2026 at a weighted average price of $15.045, totaling $225,675; prices ranged from $15.00 to $15.10.
  • The sale executed automatically under a Rule 10b5-1 trading plan adopted December 3, 2025; post-transaction direct ownership is 819,326 shares and indirect holdings include 65,000 shares in an IRA.
  • NPKI’s stock has risen 192% over the past year and trades near a 52-week high of $15.96; the company reported Q4 2025 adjusted EPS of $0.13 (vs $0.10 expected) and revenue of $75.2 million (vs $68.85 million expected), while an InvestingPro Fair Value assessment indicates the shares may be overvalued.

Gregg Piontek, Senior Vice President and Chief Financial Officer of NPK International (NPKI), sold 15,000 shares of the company’s common stock on April 9, 2026, according to a Securities and Exchange Commission filing. The shares were sold at a weighted average price of $15.045, producing proceeds of $225,675. Reported trade prices ranged between $15.00 and $15.10.

The disposition was carried out under a pre-arranged Rule 10b5-1 trading plan that Piontek adopted on December 3, 2025, and was executed automatically in accordance with that arrangement. After the transaction, Piontek directly owns 819,326 shares of NPK International. He additionally holds 65,000 shares indirectly through an individual retirement account.

The sale comes while NPK International’s stock has rallied significantly over the past year, gaining 192% and trading close to a 52-week high of $15.96. At the same time, InvestingPro’s Fair Value assessment flags the shares as appearing overvalued at current market levels.

Investors’ attention to NPK International has intensified in part because the company reported fourth-quarter 2025 results that exceeded consensus forecasts. The firm reported adjusted earnings per share of $0.13 for the quarter, ahead of the $0.10 that was expected, representing a 30% surprise to estimates. Revenue for the period was reported at $75.2 million, surpassing the $68.85 million analysts had forecast.

Those results - both the EPS beat and the top-line outperformance - have drawn investor and analyst focus on NPK International’s near-term financial trajectory. Market participants are watching how the combination of elevated share price, recent insider selling under an automatic plan, and stronger-than-expected quarterly results will influence future coverage and investor interest.


Context and mechanics:

  • The sale involved 15,000 shares at a weighted average of $15.045, with a total value of $225,675 and per-share prices ranging from $15.00 to $15.10.
  • The transaction was implemented under a Rule 10b5-1 plan adopted December 3, 2025, meaning it was an automatic, pre-specified sale.
  • Following the sale, Piontek directly holds 819,326 shares and indirectly holds 65,000 shares via an IRA.

For stakeholders, the combination of an insider sale under a pre-arranged plan and recent beats on earnings and revenue contributes to a nuanced picture: the company delivered stronger-than-expected quarterly metrics, yet third-party valuation work assesses the stock as overvalued at current market levels.

Risks

  • Valuation risk - InvestingPro’s Fair Value assessment suggests NPKI may be overvalued at current market prices, which could affect investor expectations and market sentiment. This impacts equity investors and analysts covering the stock.
  • Interpretation risk of the insider sale - because the disposal was executed under a pre-arranged Rule 10b5-1 plan, observers have limited ability to infer intent from the transaction; this creates uncertainty for shareholders and market participants.
  • Market response uncertainty - although the company beat Q4 2025 earnings and revenue estimates, it is unclear how these results, taken together with the recent insider sale and elevated share price, will influence future analyst ratings and investor behavior in equity markets.

More from Insider Trading

Photronics CEO Disposes of $5.2M in Stock as Shares Near Yearly High Apr 10, 2026 Broadcom ISG President Disposes $10.6M in Shares Over Two Days Apr 10, 2026 Adaptive Biotechnologies CPO Sells $340K in Stock as Shares Slip; Options Also Exercised Apr 10, 2026 Adaptive Biotechnologies CSO Disposes of $148,500 in Shares Ahead of Price Drop Apr 10, 2026 Whitehawk Therapeutics CEO Sells $49,010 in Stock to Cover RSU Taxes Apr 10, 2026